Research Peptides
All compounds research-use-only. Synthesized & verified in-house.
Selective pentapeptide GHSR agonist. Pure GHRP research compound with minimal off-target receptor activity.
GHK-Cu 50mg + KPV 10mg + BPC-157 10mg + TB-500 10mg. Four-peptide advanced regeneration blend.
GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg. Three-peptide skin & systemic regeneration blend.
TB-500 5mg + BPC-157 5mg co-lyophilised blend. Combined Tβ4 fragment + gastric-juice-derived pentadecapeptide.
Triple GLP-1 / GIP / glucagon receptor agonist research peptide. Available in 10mg – 60mg vials.
Glycyl-L-histidyl-L-lysine copper complex. Naturally occurring tripeptide used in dermatological and matrix-remodelling research.
Cyclic α-MSH analogue. Non-selective melanocortin receptor agonist for pigmentation and metabolic-receptor research.
Pre-blended GHRH analogue (CJC-1295 without DAC) + selective GHRP (Ipamorelin). Standard research synergy preparation.
Dual GIP / GLP-1 receptor co-agonist. Used in research investigating incretin synergy and metabolic signalling.
Long-acting GLP-1 receptor agonist analogue. Research compound for incretin pathway and glucose homeostasis studies.
Synthetic Thymosin β-4 active fragment. Used in cell migration, angiogenesis, and tissue regeneration research.
Pentadecapeptide (15 aa) derived from gastric juice protein. Research peptide for tissue repair and angiogenesis studies.